ANI Pharmaceuticals (ANIP)

[auh2oman]

Magic Mushrooms...

ANI has filed an application to import the active ingredient in these particular fungi:


The substance Psilocybin (7437) will be used to support formulation development and clinical trial research.


https://www.federalregister.gov/documents/2022/03/08/2022-04803/importer-of-controlled-substances-application-ani-pharmaceuticals-inc

Psilocybin has shown in recent studies to have a beneficial effect with people suffering from depression:

https://www.verywellmind.com/psilocybin-effective-for-depression-a-year-post-treatment-study-finds-5221244


There are currently 91 clinical studies on ClinicalTrials.org:


https://clinicaltrials.gov/ct2/results?cond=&term=psilocybin&cntry=&state=&city=&dist=


This is an interesting development that the Company is pursuing. Below is an informative article pertaining to the future of this particular treatment:

https://www.theguardian.com/science/2021/nov/07/will-the-magic-of-psychadelics-transform-psychiatry